NSU Newsroom

SharkBytes

Horizons

This version of NSU News has been archived as of February 28, 2019. To search through archived articles, visit nova.edu/search. To access the new version of NSU News, visit news.nova.edu.

This version of SharkBytes has been archived as of February 28, 2019. To search through archived articles, visit nova.edu/search. To access the new version of SharkBytes, visit sharkbytes.nova.edu.

News Releases Archive

Contact

Division of Public Relations and Marketing Communications
Nova Southeastern University
3301 College Avenue
Fort Lauderdale, Florida 33314-7796

nova.edu/prmc

SharkBytes Archives

Contact

Division of Public Relations and Marketing Communications
Nova Southeastern University
3301 College Avenue
Fort Lauderdale, Florida 33314-7796

(954) 262-5353
(800) 541-6682 x25353
Fax: (954) 262-3954
communications@nova.edu

NSU appoints New Schemel Professor for Neuro Immune Medicine

Nancy Klimas, M.D., director of the Institute for Neuro Immune Medicine; Mary Ann Fletcher, Ph.D., Schemel Professor for Neuro Immune Medicine; Robert Schemel, Schemel Family Foundation; and Anthony J. Silvagni, D.O., Pharm.D., M.Sc., dean of the NSU College of Osteopathic Medicine

Nancy Klimas, M.D., director of the Institute for Neuro Immune Medicine; Mary Ann Fletcher, Ph.D., Schemel Professor for Neuro Immune Medicine; Robert Schemel, Schemel Family Foundation; and Anthony J. Silvagni, D.O., Pharm.D., M.Sc., dean of the NSU College of Osteopathic Medicine

NSU College of Osteopathic Medicine Dean Anthony J. Silvagni, D.O., Pharm.D., M.Sc., recently announced the appointment of Mary Ann Fletcher, Ph.D., as the first Schemel Professor for Neuro Immune Medicine. The Schemel Professorship was established in 2013 through a $2 million endowment from the Schemel Family Foundation.

In her new role, Fletcher will oversee the research lab and conduct proteomic and genomic research at the NSU College of Medicine’s Institute for Neuro Immune Medicine. Located at NSU’s main campus in Davie and led by Nancy Klimas, M.D., the Institute is the first in the nation to study neuroinflammatory and neurodegenerative disorders such as chronic fatigue syndrome/myalgic encephalomyelitis, Gulf War Illness, Parkinson’s disease and multiple sclerosis using the newest proteomic, genomic and computational techniques. The program recently received a $4.1 million grant from the Department of Defense to study Gulf War Illness.

“I am honored and grateful to the Schemel family and NSU for believing in me and allowing me to devote my efforts to helping find better treatments for these diseases which impact so many people and deserve our attention and resources,” said Fletcher.